A citation-based method for searching scientific literature

Weiqin Jiang, Yinjun He, Wenguang He, Guosheng Wu, Xile Zhou, Qinsong Sheng, Weixiang Zhong, Yimin Lu, Yongfeng Ding, Qi Lu, Feng Ye, Hanju Hua. Front Immunol 2021
Times Cited: 36







List of co-cited articles
248 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity.
Camilla Calandrini, Frans Schutgens, Rurika Oka, Thanasis Margaritis, Tito Candelli, Luka Mathijsen, Carola Ammerlaan, Ravian L van Ineveld, Sepide Derakhshan, Sanne de Haan,[...]. Nat Commun 2020
106
2

Organoids as Oracles for Precision Medicine in Rectal Cancer.
Kevin S Kolahi, Michitaka Nakano, Calvin J Kuo. Cell Stem Cell 2020
9
11

Xenograft and organoid model systems in cancer research.
Margit Bleijs, Marc van de Wetering, Hans Clevers, Jarno Drost. EMBO J 2019
135
2

Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.
Mami Matano, Shoichi Date, Mariko Shimokawa, Ai Takano, Masayuki Fujii, Yuki Ohta, Toshiaki Watanabe, Takanori Kanai, Toshiro Sato. Nat Med 2015
630
2


Pancreatic cancer organoids recapitulate disease and allow personalized drug screening.
Else Driehuis, Arne van Hoeck, Kat Moore, Sigrid Kolders, Hayley E Francies, M Can Gulersonmez, Edwin C A Stigter, Boudewijn Burgering, Veerle Geurts, Ana Gracanin,[...]. Proc Natl Acad Sci U S A 2019
155
2

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.
Georgios Vlachogiannis, Somaieh Hedayat, Alexandra Vatsiou, Yann Jamin, Javier Fernández-Mateos, Khurum Khan, Andrea Lampis, Katherine Eason, Ian Huntingford, Rosemary Burke,[...]. Science 2018
738
2

Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies.
Sandro Nuciforo, Isabel Fofana, Matthias S Matter, Tanja Blumer, Diego Calabrese, Tujana Boldanova, Salvatore Piscuoglio, Stefan Wieland, Femke Ringnalda, Gerald Schwank,[...]. Cell Rep 2018
173
2

Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases.
Fleur Weeber, Marc van de Wetering, Marlous Hoogstraat, Krijn K Dijkstra, Oscar Krijgsman, Thomas Kuilman, Christa G M Gadellaa-van Hooijdonk, Daphne L van der Velden, Daniel S Peeper, Edwin P J G Cuppen,[...]. Proc Natl Acad Sci U S A 2015
250
2

Modeling human adaptive immune responses with tonsil organoids.
Lisa E Wagar, Ameen Salahudeen, Christian M Constantz, Ben S Wendel, Michael M Lyons, Vamsee Mallajosyula, Lauren P Jatt, Julia Z Adamska, Lisa K Blum, Neha Gupta,[...]. Nat Med 2021
50
2

A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation.
Yuan-Hung Lo, Kevin S Kolahi, Yuhong Du, Chiung-Ying Chang, Andrey Krokhotin, Ajay Nair, Walter D Sobba, Kasper Karlsson, Sunny J Jones, Teri A Longacre,[...]. Cancer Discov 2021
25
4

Clonal replacement of tumor-specific T cells following PD-1 blockade.
Kathryn E Yost, Ansuman T Satpathy, Daniel K Wells, Yanyan Qi, Chunlin Wang, Robin Kageyama, Katherine L McNamara, Jeffrey M Granja, Kavita Y Sarin, Ryanne A Brown,[...]. Nat Med 2019
505
2

Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients.
Salo N Ooft, Fleur Weeber, Krijn K Dijkstra, Chelsea M McLean, Sovann Kaing, Erik van Werkhoven, Luuk Schipper, Louisa Hoes, Daniel J Vis, Joris van de Haar,[...]. Sci Transl Med 2019
244
2

Applications of Organoids for Cancer Biology and Precision Medicine.
Yuan-Hung Lo, Kasper Karlsson, Calvin J Kuo. Nat Cancer 2020
32
3


Tumor infiltrating lymphocyte clusters are associated with response to immune checkpoint inhibition in BRAF V600E/K mutated malignant melanomas.
Sebastian Klein, Cornelia Mauch, Klaus Brinker, Ka-Won Noh, Sonja Knez, Reinhard Büttner, Alexander Quaas, Doris Helbig. Sci Rep 2021
14
7

The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort.
Diane Damotte, Sarah Warren, Jennifer Arrondeau, Pascaline Boudou-Rouquette, Audrey Mansuet-Lupo, Jérôme Biton, Hanane Ouakrim, Marco Alifano, Claire Gervais, Audrey Bellesoeur,[...]. J Transl Med 2019
48
2

Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts.
John W Cassidy, Carlos Caldas, Alejandra Bruna. Cancer Res 2015
195
2

The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design.
Keith T Flaherty, Robert Gray, Alice Chen, Shuli Li, David Patton, Stanley R Hamilton, Paul M Williams, Edith P Mitchell, A John Iafrate, Jeffrey Sklar,[...]. J Natl Cancer Inst 2020
70
2

A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response.
Kelli A Connolly, Manik Kuchroo, Aarthi Venkat, Achia Khatun, Jiawei Wang, Ivana William, Noah I Hornick, Brittany L Fitzgerald, Martina Damo, Moujtaba Y Kasmani,[...]. Sci Immunol 2021
34
2


Patient-Derived Cancer Organoids as Predictors of Treatment Response.
Maikel Verduin, Ann Hoeben, Dirk De Ruysscher, Marc Vooijs. Front Oncol 2021
15
6

Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors.
Giosue Scognamiglio, Annarosaria De Chiara, Antonina Parafioriti, Elisabetta Armiraglio, Flavio Fazioli, Michele Gallo, Laura Aversa, Rosa Camerlingo, Francesco Cacciatore, Gianluca Colella,[...]. Br J Cancer 2019
41
2

Prospective experimental treatment of colorectal cancer patients based on organoid drug responses.
S N Ooft, F Weeber, L Schipper, K K Dijkstra, C M McLean, S Kaing, J van de Haar, W Prevoo, E van Werkhoven, P Snaebjornsson,[...]. ESMO Open 2021
21
4


In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening.
Andrea R Mazzocchi, Shiny A P Rajan, Konstantinos I Votanopoulos, Adam R Hall, Aleksander Skardal. Sci Rep 2018
70
2

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.
Russell W Jenkins, Amir R Aref, Patrick H Lizotte, Elena Ivanova, Susanna Stinson, Chensheng W Zhou, Michaela Bowden, Jiehui Deng, Hongye Liu, Diana Miao,[...]. Cancer Discov 2018
239
2

CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation.
Jiehui Deng, Eric S Wang, Russell W Jenkins, Shuai Li, Ruben Dries, Kathleen Yates, Sandeep Chhabra, Wei Huang, Hongye Liu, Amir R Aref,[...]. Cancer Discov 2018
322
2

Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture.
Xingnan Li, Lincoln Nadauld, Akifumi Ootani, David C Corney, Reetesh K Pai, Olivier Gevaert, Michael A Cantrell, Paul G Rack, James T Neal, Carol W-M Chan,[...]. Nat Med 2014
248
2

Tumor-Infiltrating Lymphocyte Function Predicts Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Joseph Cherng Huei Kong, Glen Robert Guerra, Rosemary Magdalena Millen, Sara Roth, Huiling Xu, Paul Joseph Neeson, Phillip Kevin Darcy, Michael Henry Kershaw, Shienny Sampurno, Jordane Malaterre,[...]. JCO Precis Oncol 2018
18
5

An Organoid-Based Preclinical Model of Human Gastric Cancer.
Nina G Steele, Jayati Chakrabarti, Jiang Wang, Jacek Biesiada, Loryn Holokai, Julie Chang, Lauren M Nowacki, Jennifer Hawkins, Maxime Mahe, Nambirajan Sundaram,[...]. Cell Mol Gastroenterol Hepatol 2019
59
2

A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening.
Helen H N Yan, Hoi Cheong Siu, Simon Law, Siu Lun Ho, Sarah S K Yue, Wai Yin Tsui, Dessy Chan, April S Chan, Stephanie Ma, Ka On Lam,[...]. Cell Stem Cell 2018
263
2

Sequential cancer mutations in cultured human intestinal stem cells.
Jarno Drost, Richard H van Jaarsveld, Bas Ponsioen, Cheryl Zimberlin, Ruben van Boxtel, Arjan Buijs, Norman Sachs, René M Overmeer, G Johan Offerhaus, Harry Begthel,[...]. Nature 2015
588
2

A rectal cancer organoid platform to study individual responses to chemoradiation.
Karuna Ganesh, Chao Wu, Kevin P O'Rourke, Bryan C Szeglin, Youyun Zheng, Charles-Etienne Gabriel Sauvé, Mohammad Adileh, Isaac Wasserman, Michael R Marco, Amanda S Kim,[...]. Nat Med 2019
182
2

An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer.
Paula Voabil, Marjolein de Bruijn, Lisanne M Roelofsen, Sanne H Hendriks, Simone Brokamp, Marlous van den Braber, Annegien Broeks, Joyce Sanders, Petra Herzig, Alfred Zippelius,[...]. Nat Med 2021
46
2

Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages.
Jennifer M Rosenbluth, Ron C J Schackmann, G Kenneth Gray, Laura M Selfors, Carman Man-Chung Li, Mackenzie Boedicker, Hendrik J Kuiken, Andrea Richardson, Jane Brock, Judy Garber,[...]. Nat Commun 2020
67
2

Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center.
Pierre Sesques, Emmanuelle Ferrant, Violaine Safar, Florent Wallet, Jérémie Tordo, Anthony Dhomps, Lionel Karlin, Gabriel Brisou, Marlène Vercasson, Carole Hospital-Gustem,[...]. Am J Hematol 2020
48
2

IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
Sujin Kang, Toshio Tanaka, Hitomi Inoue, Chikako Ono, Shoji Hashimoto, Yoshiyuki Kioi, Hisatake Matsumoto, Hiroshi Matsuura, Tsunehiro Matsubara, Kentaro Shimizu,[...]. Proc Natl Acad Sci U S A 2020
111
2

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma.
Laetitia Vercellino, Roberta Di Blasi, Salim Kanoun, Benoit Tessoulin, Cedric Rossi, Maud D'Aveni-Piney, Lucie Obéric, Caroline Bodet-Milin, Pierre Bories, Pierre Olivier,[...]. Blood Adv 2020
87
2

Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib.
Cameron J Turtle, Kevin A Hay, Laïla-Aïcha Hanafi, Daniel Li, Sindhu Cherian, Xueyan Chen, Brent Wood, Arletta Lozanski, John C Byrd, Shelly Heimfeld,[...]. J Clin Oncol 2017
395
2

Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells.
Juliane Gust, Kevin A Hay, Laïla-Aïcha Hanafi, Daniel Li, David Myerson, Luis F Gonzalez-Cuyar, Cecilia Yeung, W Conrad Liles, Mark Wurfel, Jose A Lopez,[...]. Cancer Discov 2017
661
2

Neutrophil Maturity in Cancer.
John B G Mackey, Seth B Coffelt, Leo M Carlin. Front Immunol 2019
47
2

Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56.
Fan Zou, Lijuan Lu, Jun Liu, Baijin Xia, Wanying Zhang, Qifei Hu, Weiwei Liu, Yiwen Zhang, Yingtong Lin, Shuliang Jing,[...]. Nat Commun 2019
34
2

State of the art in CAR T cell therapy for CD19+ B cell malignancies.
Matthew J Frigault, Marcela V Maus. J Clin Invest 2020
46
2

Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia.
Bianca D Santomasso, Jae H Park, Darin Salloum, Isabelle Riviere, Jessica Flynn, Elena Mead, Elizabeth Halton, Xiuyan Wang, Brigitte Senechal, Terence Purdon,[...]. Cancer Discov 2018
385
2


Diverse Functions of Macrophages in Different Tumor Microenvironments.
Ming Yang, Daniel McKay, Jeffrey W Pollard, Claire E Lewis. Cancer Res 2018
211
2


The microenvironment in mature B-cell malignancies: a target for new treatment strategies.
Jan A Burger, Paolo Ghia, Andreas Rosenwald, Federico Caligaris-Cappio. Blood 2009
404
2

Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms.
Xiaowen Huang, Basharat Hussain, Junlei Chang. CNS Neurosci Ther 2021
62
2


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.